Avalere Enhances Market Access Capabilities with Additions

  • This page as PDF


Avalere Health’s Market Access practice expands its team with recent hires bringing analytics, coverage strategy, and commercialization expertise.

“Ingraining value, access, and reimbursement solutions at all stages of market planning requires us to grow to address the evolving needs of our clients,” said Lance Grady, Head of Market Access at Avalere. “By adding individuals who excel in areas like pharmacoeconomic value, payer and provider perspectives, and coding, coverage, and reimbursement, we are able to expand and deepen our capabilities to address market strategy.”

Alex (Shuang) Du has joined Avalere as an associate principal. Before joining Avalere, Du was a managing consultant at The Lewin Group, where he managed various projects focusing on data analytics for commercial and government clients. He also worked with all-payer claims databases and value-based payment program evaluation.

Du has a master’s degree in healthcare administration from the University of Michigan, Ann Arbor, a master’s degree in statistics from Michigan Technological University, and a bachelor’s degree in economics from Nankai University in Tianjin, China.

Jordan Banks comes to Avalere as a senior consultant. Banks leverages her 10 years of research and analytics experience with life sciences organizations, employer groups, health plans, providers, and academic publications to provide support and strategic insights for healthcare organizations. Prior to joining Avalere, Banks was a director of reporting and analytics at Anthem where she managed analytics for a large national commercial employer.

Banks received her doctorate in health services research with a focus in economics from the University of Washington. She received her Master of Public Affairs with a concentration in public policy analysis and a Bachelor of Science in business from Indiana University.

As an associate principal in the Market Access practice, Mike deMilt has more than 15 years of industry experience leading projects spanning all stages of development across therapeutic areas and global markets. DeMilt advises pharmaceutical clients on a broad range of topics including early value and access strategy, drug pricing, payer positioning, and due diligence. Prior to joining Avalere, deMilt was a vice president at Destum Partners where he led consulting engagements to shape business strategies and support corporate transactions.

DeMilt has a master’s degree in biotechnology enterprise and entrepreneurship from The Johns Hopkins University and a Bachelor of Science degree in biology from Radford University.

Joshua Perro has joined Avalere as a senior manager. His experience has been focused on providing clients strategic guidance on access, reimbursement, and commercialization challenges for clients, including pricing and contracting strategy. Prior to Avalere, Perro worked as a management consultant at Deloitte.

Joshua received his Bachelor of Arts degree in political science from the College of the Holy Cross.

Mariia Salova comes to Avalere as a senior manager. Before joining Avalere, Salova worked for a boutique consulting company as a market access consultant where she helped clients with commercial strategy development, creation of evidence-based value propositions, and value communication.

Mariia received her general medicine and medical psychology degrees from Bogomolets National Medical University in Ukraine and a Master of Science degree in healthcare management from The Johns Hopkins University.

As a manager at Avalere, Pamela Gortman brings a vast background in coding, auditing and compliance to support clients with research and analysis in coding and reimbursement.

Gortman received her Associate of Science degree in health information technology from St. Petersburg College. She also holds coding credentials from the American Health Information Management Association and the American Academy of Professional Coders, including Certified Coding Specialist, Certified Professional Coder, Certified Documentation Expert Outpatient, and Certified Professional Medical Auditor.

Bar Stern has joined Avalere as a manager. Stern will use his background in market access consulting, statistical analysis, and creative problem solving to support clients across the healthcare sector. Stern has a specialization in cell and gene therapy, previously working at The Dedham Group as a consultant in the oncology and rare disease space.

Stern received his Master of Science and Bachelor of Science degrees in biomedical engineering from Binghamton University.

As a senior associate at Avalere, Montrell Taylor has real-world clinical experience as a pharmacist allows him to leverage his knowledge of the industry to support various clients.

Taylor received his Doctor of Pharmacy degree from Howard University and a Bachelor of Science in biochemistry from Middle Tennessee State University.

Tiana Easterling comes to Avalere as a senior associate. Her experience in medical coding and reimbursements allows her to assist clients in healthcare coding, related payment policies and policy impacts.

Easterling received her Bachelor of Arts degree in business administration and healthcare management at the Florida Institute of Technology.

Sissy Davis has joined Avalere as a senior associate. Sissy’s experience in public and global health allows her to provide a unique perspective to guide stakeholders. Davis is returning to the Avalere Market Access team with subject matter expertise in Medicare Part D, end-stage renal disease, new technology add-on payments, and payer strategy.

Davis received her Bachelor of Science degree in public health and international development from Tulane University.

“All new hires bring unique perspectives to our Market Access team that will allow Avalere to continue to serve our clients with the highest quality of care,” added Grady

To receive Avalere updates, connect with us.

Webinar | A Closer Look at Patient Support On June 6 at 2 PM ET, Avalere experts will explore how potential implications of the Inflation Reduction Act (IRA)’s out-of-pocket cap, in addition to other key regulatory and policy activities shaping benefit design and patient cost-share (e.g., EHB), could impact patient commercial and foundation assistance. Learn More
From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top